BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 18773751)

  • 1. [Obesity and hypertension].
    Verdecchia P; Trimarco B
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):54S-59S. PubMed ID: 18773751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in obesity.
    Redon J
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):344-53. PubMed ID: 11887431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta2- and beta3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals.
    Kawaguchi H; Masuo K; Katsuya T; Sugimoto K; Rakugi H; Ogihara T; Tuck ML
    Hypertens Res; 2006 Dec; 29(12):951-9. PubMed ID: 17378367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
    Golan E; Tal B; Dror Y; Korzets Z; Vered Y; Weiss E; Bernheim J
    Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overweight, obesity, and blood pressure: the effects of modest weight reduction.
    Mertens IL; Van Gaal LF
    Obes Res; 2000 May; 8(3):270-8. PubMed ID: 10832771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor.
    Masuo K; Katsuya T; Kawaguchi H; Fu Y; Rakugi H; Ogihara T; Tuck ML
    Am J Hypertens; 2005 Nov; 18(11):1508-16. PubMed ID: 16280290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Leiter LA; Abbott D; Campbell NR; Mendelson R; Ogilvie RI; Chockalingam A
    CMAJ; 1999 May; 160(9 Suppl):S7-12. PubMed ID: 10333848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy balance and blood-pressure regulation. Update and future perspectives.
    Mancini M; Strazzullo P
    J Clin Hypertens; 1986 Jun; 2(2):148-53. PubMed ID: 3531414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating ghrelin levels in obese women: a possible association with hypertension.
    Oner-Iyidoğan Y; Koçak H; Gürdöl F; Oner P; Issever H; Esin D
    Scand J Clin Lab Invest; 2007; 67(5):568-76. PubMed ID: 17763194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure.
    Lambert E; Straznicky N; Eikelis N; Esler M; Dawood T; Masuo K; Schlaich M; Lambert G
    J Hypertens; 2007 Jul; 25(7):1411-9. PubMed ID: 17563563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma angiotensinII, leptin and arterial blood pressure.
    Al-Hazimi AM; Syiamic AY
    Saudi Med J; 2004 Sep; 25(9):1193-8. PubMed ID: 15448764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin and heart sympathetic activity in normotensive obese and non-obese subjects.
    Amador N; Pérez-Luque E; Malacara JM; Guízar JM; Paniagua R; Lara S
    Ital Heart J; 2004 Jan; 5(1):29-35. PubMed ID: 15080578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of short-term weight changes and weight cycling with incidence of essential hypertension in the EPIC-Potsdam Study.
    Schulz M; Liese AD; Boeing H; Cunningham JE; Moore CG; Kroke A
    J Hum Hypertens; 2005 Jan; 19(1):61-7. PubMed ID: 15343355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic-leptin relationship in obesity: effect of weight loss.
    Quilliot D; Böhme P; Zannad F; Ziegler O
    Metabolism; 2008 Apr; 57(4):555-62. PubMed ID: 18328360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of obesity-related hypertension].
    Skoczylas A
    Wiad Lek; 2006; 59(5-6):403-6. PubMed ID: 17017491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated blood pressure in relation to overweight and obesity among children in a rural Canadian community.
    Salvadori M; Sontrop JM; Garg AX; Truong J; Suri RS; Mahmud FH; Macnab JJ; Clark WF
    Pediatrics; 2008 Oct; 122(4):e821-7. PubMed ID: 18829779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between body weight and blood pressure.
    Staessen J; Fagard R; Amery A
    J Hum Hypertens; 1988 Dec; 2(4):207-17. PubMed ID: 3070038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management.
    Kotchen TA
    Am J Hypertens; 2010 Nov; 23(11):1170-8. PubMed ID: 20706196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).
    Sharma AM; Caterson ID; Coutinho W; Finer N; Van Gaal L; Maggioni AP; Torp-Pedersen C; Bacher HP; Shepherd GM; James WP;
    Diabetes Obes Metab; 2009 Mar; 11(3):239-50. PubMed ID: 18671798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.